Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Matthew Mikulski"'
Autor:
Matthew Mikulski, Andrew Well, Daniel P. Shmorhun, Carlos Mery, Ziv Beckerman, Arnold L. Fenrich, Charles D. Fraser
Publikováno v:
Heart Rhythm. 20:S439
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c5f70734437048cb3a5d705b272346a7
https://doi.org/10.1016/j.hrthm.2023.03.968
https://doi.org/10.1016/j.hrthm.2023.03.968
Autor:
Matthew Mikulski, Andrew Well, Daniel Shmorhun, Sergio Estevez, Charles D. Fraser, Carlos M. Mery, Arnold L. Fenrich
Publikováno v:
Journal of the American College of Cardiology. 81:1549
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::f6f781e30085da22cabb57fc5efa45bc
https://doi.org/10.1016/s0735-1097(23)01993-9
https://doi.org/10.1016/s0735-1097(23)01993-9
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:180-180
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::47033236577445779136bcd978a8d1e4
https://doi.org/10.1038/scibx.2008.180
https://doi.org/10.1038/scibx.2008.180
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:157-157
Researchers at Attagene have developed a method for simultaneously quantifying the activity of dozens of transcription factors in cells. Genomics and transcriptomics service providers think the tool could have utility in toxicology and early drug dis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::b1f3e79756a7f64dc37c3589686b6025
https://doi.org/10.1038/scibx.2008.157
https://doi.org/10.1038/scibx.2008.157
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:130-130
Canadian researchers have shown that IL-7 initiates disease in an animal model of type 2 diabetes and potentially other autoimmune conditions, but targeting the cytokine and its receptor will prove tricky.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::628692810bcd1f04bbba7da69ad64b6f
https://doi.org/10.1038/scibx.2008.130
https://doi.org/10.1038/scibx.2008.130
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:28-28
Although the utility of peroxisome proliferation–activated receptor-a agonists, such as fenofibrates, in lipid disorders is well known, Harvard University researchers have shown the utility of the compounds in cancer, which could increase the $1.6
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51f1d45dbc2fb1a4ff56be488fb9e4e3
https://doi.org/10.1038/scibx.2008.28
https://doi.org/10.1038/scibx.2008.28
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:53-53
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::fc2a648074bd22218b88e4b7df9a1378
https://doi.org/10.1038/scibx.2008.53
https://doi.org/10.1038/scibx.2008.53
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:29-29
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a32dc196ae8ab94686e7449d6a83ad69
https://doi.org/10.1038/scibx.2008.29
https://doi.org/10.1038/scibx.2008.29
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:81-81
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::73983845f757b30988fcb155b46b126a
https://doi.org/10.1038/scibx.2008.81
https://doi.org/10.1038/scibx.2008.81
Autor:
Matthew Mikulski
Publikováno v:
Science-Business eXchange. 1:1-1
Findings by researchers at the University of North Carolina suggest that anti-CD200 antibodies could be used as melanoma therapeutics. The discovery could be a windfall for Alexion and Trillium, which have anti-CD200 antibodies in development for blo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e9fb9b1d9e021ead9489f032e9900e7c
https://doi.org/10.1038/scibx.2008.1
https://doi.org/10.1038/scibx.2008.1